阳普医疗
(300030)
| 流通市值：17.86亿 | | | 总市值：20.28亿 |
| 流通股本：2.72亿 | | | 总股本：3.09亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 215,097,732 | 95,314,773.95 | 486,260,010.42 | 349,231,193.17 |
| 营业收入 | 215,097,732 | 95,314,773.95 | 486,260,010.42 | 349,231,193.17 |
| 二、营业总成本 | 182,785,118.63 | 79,504,810.86 | 452,644,635.72 | 329,782,171.95 |
| 营业成本 | 112,486,954.62 | 47,078,220.38 | 277,137,852.43 | 201,576,225.61 |
| 税金及附加 | 3,267,822.69 | 1,816,351.46 | 7,046,889.57 | 4,871,568.64 |
| 销售费用 | 28,738,943.55 | 14,721,674.17 | 66,118,872.77 | 46,275,782.45 |
| 管理费用 | 30,790,591.67 | 14,511,888.46 | 74,206,577.82 | 55,902,524.68 |
| 研发费用 | 9,442,536.88 | 4,435,320.25 | 23,653,365.3 | 17,942,654.55 |
| 财务费用 | -1,941,730.78 | -3,058,643.86 | 4,481,077.83 | 3,213,416.02 |
| 其中:利息费用 | 1,571,751.82 | 924,189.43 | 5,139,787.59 | 4,021,649.85 |
| 其中:利息收入 | 4,717,723.69 | 4,640,639.01 | 1,089,930.19 | 823,202.61 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -6,071,000 | 0 | -10,171,400 | -8,170,700 |
| 加:投资收益 | 1,032,405.86 | 1,041,345.07 | 20,484,949.48 | 18,710,906.35 |
| 资产处置收益 | 18,517.63 | -25,890.35 | 2,087,236.69 | -919,156.46 |
| 资产减值损失(新) | -1,576,173.52 | 0 | -35,222,408.13 | -4,273,714.17 |
| 信用减值损失(新) | 9,516,955.75 | 8,952,045.46 | 6,302,289.71 | -1,529,119.03 |
| 其他收益 | 1,982,674.16 | 1,042,140.15 | 3,756,426.48 | 3,963,115.57 |
| 四、营业利润 | 37,215,993.25 | 26,819,603.42 | 20,852,468.93 | 27,230,353.48 |
| 加:营业外收入 | 359,726.52 | 480.05 | 4,007,024.51 | 1,703,964.25 |
| 减:营业外支出 | 102,903 | 765.74 | 2,141,934.2 | 1,007,566.09 |
| 五、利润总额 | 37,472,816.77 | 26,819,317.73 | 22,717,559.24 | 27,926,751.64 |
| 减:所得税费用 | 6,152,427.3 | 4,852,659.76 | 7,503,346.26 | 4,481,451.14 |
| 六、净利润 | 31,320,389.47 | 21,966,657.97 | 15,214,212.98 | 23,445,300.5 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 31,320,389.47 | 21,966,657.97 | 15,214,212.98 | 23,445,300.5 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 30,814,928.63 | 21,679,634.29 | 14,530,384.08 | 24,044,095.67 |
| 少数股东损益 | 505,460.84 | 287,023.68 | 683,828.9 | -598,795.17 |
| 扣除非经常损益后的净利润 | 24,229,883.38 | 11,475,257.56 | 17,977,199.02 | 30,357,702.81 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.1 | 0.07 | 0.05 | 0.08 |
| (二)稀释每股收益 | 0.1 | 0.07 | 0.05 | 0.08 |
| 八、其他综合收益 | 76,090.43 | 32,802.24 | -990,517.45 | 13,386.02 |
| 归属于母公司股东的其他综合收益 | 76,090.43 | 32,802.24 | -990,517.45 | 13,386.02 |
| 九、综合收益总额 | 31,396,479.9 | 21,999,460.21 | 14,223,695.53 | 23,458,686.52 |
| 归属于母公司股东的综合收益总额 | 30,891,019.06 | 21,712,436.53 | 13,539,866.63 | 24,057,481.69 |
| 归属于少数股东的综合收益总额 | 505,460.84 | 287,023.68 | 683,828.9 | -598,795.17 |
| 公告日期 | 2026-08-15 | 2026-04-22 | 2026-04-09 | 2025-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |